Last 12 months
Inside the activity.
41 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 2 |
| Jun 2026 | 17 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 10 | 1 |
| Sep 2026 | 11 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 4, 2025 21:37 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
Tax withholdingClass A Common Shares | 928 | $6.77 | $6,282.56 |
DisclosureSEC source: 0001712184-25-000039 · wk-form4_1741124245.xml · nonDerivative · entry 2 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,622 Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:37 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
Exercise / conversionClass A Common Shares | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000039 · wk-form4_1741124245.xml · nonDerivative · entry 1 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:36 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Share Units C · Derivative | 3,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000037 · wk-form4_1741124161.xml · derivative · entry 9 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 3,335 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:36 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Share Units A · Derivative | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000037 · wk-form4_1741124161.xml · derivative · entry 8 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 1,667 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:36 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingClass C Common Shares | 1,918 | $6.71 | $12,869.78 |
DisclosureSEC source: 0001712184-25-000037 · wk-form4_1741124161.xml · nonDerivative · entry 4 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487,311 Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:36 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Exercise / conversionClass C Common Shares | 3,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000037 · wk-form4_1741124161.xml · nonDerivative · entry 3 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:36 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingClass A Common Shares | 959 | $6.77 | $6,492.43 |
DisclosureSEC source: 0001712184-25-000037 · wk-form4_1741124161.xml · nonDerivative · entry 2 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,580 Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:36 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Exercise / conversionClass A Common Shares | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000037 · wk-form4_1741124161.xml · nonDerivative · entry 1 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:04 UTC |
Nair BalanDirector · President and CEO
|
Tax withholdingClass C Common Shares | 14,313 | $6.13 | $87,738.69 |
DisclosureSEC source: 0001712184-25-000015 · wk-form4_1738706673.xml · nonDerivative · entry 5 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,496,561 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:04 UTC |
Nair BalanDirector · President and CEO
|
GrantClass C Common Shares | 34,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000015 · wk-form4_1738706673.xml · nonDerivative · entry 4 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,510,874 F4 · kind: The Class C common shares were issued to Mr. Nair pursuant to his June 2022 election under the Issuer's deferred compensation plan to defer payment of the bonus he had earned under the Issuer's 2022 annual performance award program. Pursuant to the terms of the election in 2022 and the deferred compensation plan, the number of shares issued was determined using the closing market price of the Issuer's Class C common shares on January 31, 2025. F4 · price: The Class C common shares were issued to Mr. Nair pursuant to his June 2022 election under the Issuer's deferred compensation plan to defer payment of the bonus he had earned under the Issuer's 2022 annual performance award program. Pursuant to the terms of the election in 2022 and the deferred compensation plan, the number of shares issued was determined using the closing market price of the Issuer's Class C common shares on January 31, 2025. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:05 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
Tax withholdingClass C Common Shares | 31,067 | $6.13 | $190,440.71 |
DisclosureSEC source: 0001712184-25-000016 · wk-form4_1738706717.xml · nonDerivative · entry 5 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,191 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:05 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
GrantClass C Common Shares | 74,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000016 · wk-form4_1738706717.xml · nonDerivative · entry 4 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,258 F4 · kind: The Class C common shares were issued to Mr. Winter pursuant to his June 2020 election under the Issuer's deferred compensation plan to defer payment of the bonus he had earned under the Issuer's 2020 annual performance award program. Pursuant to the terms of the election in 2020 and the deferred compensation plan, the number of shares issued was determined using the closing market price of the Issuer's Class C common shares on January 31, 2025. F4 · price: The Class C common shares were issued to Mr. Winter pursuant to his June 2020 election under the Issuer's deferred compensation plan to defer payment of the bonus he had earned under the Issuer's 2020 annual performance award program. Pursuant to the terms of the election in 2020 and the deferred compensation plan, the number of shares issued was determined using the closing market price of the Issuer's Class C common shares on January 31, 2025. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:07 UTC |
Nair BalanDirector · President and CEO
|
Tax withholdingClass C Common Shares | 41,191 | $6.57 | $270,624.87 |
DisclosureSEC source: 0001712184-25-000008 · wk-form4_1737148012.xml · nonDerivative · entry 2 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475,734 Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:07 UTC |
Nair BalanDirector · President and CEO
|
GrantClass C Common Shares | 113,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000008 · wk-form4_1737148012.xml · nonDerivative · entry 1 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,516,925 F1 · kind: The Class C common shares were issued to Mr. Nair pursuant to his June 2023 election under the Issuer's deferred compensation plan to defer payment of the bonus he had earned under the Issuer's 2023 annual performance award program. Pursuant to the terms of the election in 2023 and the deferred compensation plan, the number of shares issued was determined using the closing market price of the Issuer's Class C common shares on January 15, 2025. F1 · price: The Class C common shares were issued to Mr. Nair pursuant to his June 2023 election under the Issuer's deferred compensation plan to defer payment of the bonus he had earned under the Issuer's 2023 annual performance award program. Pursuant to the terms of the election in 2023 and the deferred compensation plan, the number of shares issued was determined using the closing market price of the Issuer's Class C common shares on January 15, 2025. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:04 UTC |
DE ANGOITIA ALFONSODirector
|
GrantClass C Common Shares | 1,271 | $6.34 | $8,058.14 |
DisclosureSEC source: 0001712184-25-000004 · wk-form4_1735938251.xml · nonDerivative · entry 2 DE ANGOITIA ALFONSO · CIK 0001724519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,579 F1 · price: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:04 UTC |
DE ANGOITIA ALFONSODirector
|
GrantClass A Common Shares | 635 | $6.36 | $4,038.60 |
DisclosureSEC source: 0001712184-25-000004 · wk-form4_1735938251.xml · nonDerivative · entry 1 DE ANGOITIA ALFONSO · CIK 0001724519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,053 F1 · price: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:02 UTC |
Zinterhofer Eric LouisDirector
|
GrantClass C Common Shares | 2,888 | $6.34 | $18,309.92 |
DisclosureSEC source: 0001712184-25-000002 · wk-form4_1735938156.xml · nonDerivative · entry 2 Zinterhofer Eric Louis · CIK 0001267621 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Searchlight Capital Partners, L.P. Disclosed balance after: 99,604 F1 · price: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on December 31, 2024. F2 · ownership.nature: The securities are owned by Searchlight Capital Partners, L.P. ("SCP"). Searchlight Capital Partners, LLC ("SCP LLC") is the general partner of SCP and the Reporting Person is a member of SCP LLC. By reason of the provisions of Rule 16a-1, the Reporting Person may be deemed to be the beneficial owner of the securities beneficially owned by SCP. The Reporting Person does not alone have dispositive or voting power with respect to any securities owned, directly or indirectly, by SCP. The Reporting Person hereby disclaims beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:02 UTC |
Zinterhofer Eric LouisDirector
|
GrantClass A Common Shares | 1,444 | $6.36 | $9,183.84 |
DisclosureSEC source: 0001712184-25-000002 · wk-form4_1735938156.xml · nonDerivative · entry 1 Zinterhofer Eric Louis · CIK 0001267621 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Searchlight Capital Partners, L.P. Disclosed balance after: 45,708 F1 · price: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on December 31, 2024. F2 · ownership.nature: The securities are owned by Searchlight Capital Partners, L.P. ("SCP"). Searchlight Capital Partners, LLC ("SCP LLC") is the general partner of SCP and the Reporting Person is a member of SCP LLC. By reason of the provisions of Rule 16a-1, the Reporting Person may be deemed to be the beneficial owner of the securities beneficially owned by SCP. The Reporting Person does not alone have dispositive or voting power with respect to any securities owned, directly or indirectly, by SCP. The Reporting Person hereby disclaims beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:05 UTC |
PADDICK BRENDAN JDirector
|
GrantClass C Common Shares | 2,657 | $6.34 | $16,845.38 |
DisclosureSEC source: 0001712184-25-000006 · wk-form4_1735938341.xml · nonDerivative · entry 2 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,942,751 F1 · price: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:05 UTC |
PADDICK BRENDAN JDirector
|
GrantClass A Common Shares | 1,328 | $6.36 | $8,446.08 |
DisclosureSEC source: 0001712184-25-000006 · wk-form4_1735938341.xml · nonDerivative · entry 1 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,438,846 F1 · price: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Feb 4, 2025 22:04 UTC |
Nair BalanDirector · President and CEO
|
GrantClass C Common Shares | 470 | $6.34 | $2,979.80 |
DisclosureSEC source: 0001712184-25-000015 · wk-form4_1738706673.xml · nonDerivative · entry 3 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,476,304 F3 · kind: These shares were acquired under the Liberty Latin America Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2024 Filed Feb 4, 2025 22:06 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
GrantClass C Common Shares | 140 | $6.34 | $887.60 |
DisclosureSEC source: 0001712184-25-000017 · wk-form4_1738706760.xml · nonDerivative · entry 3 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,894 F3 · kind: These shares were acquired under the Liberty Latin America Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2024 Filed Feb 4, 2025 22:05 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
GrantClass C Common Shares | 961 | $6.34 | $6,092.74 |
DisclosureSEC source: 0001712184-25-000016 · wk-form4_1738706717.xml · nonDerivative · entry 3 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,446 F3 · kind: These shares were acquired under the Liberty Latin America Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 29, 2024 Filed Feb 4, 2025 22:04 UTC |
Nair BalanDirector · President and CEO
|
Tax withholdingClass C Common Shares | 99 | $6.38 | $631.62 |
DisclosureSEC source: 0001712184-25-000015 · wk-form4_1738706673.xml · nonDerivative · entry 2 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475,834 F2 · kind: Represents common shares that have been withheld by the Issuer to satisfy the tax liability in connection with the issuance of shares pursuant to the ESPP's "match benefit." Read SEC document |
| December 29, 2024 Filed Feb 4, 2025 22:04 UTC |
Nair BalanDirector · President and CEO
|
GrantClass C Common Shares | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000015 · wk-form4_1738706673.xml · nonDerivative · entry 1 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475,933 F1 · kind: These shares were acquired pursuant to the "match benefit" of ESPP in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 29, 2024 Filed Feb 4, 2025 22:06 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingClass C Common Shares | 70 | $6.38 | $446.60 |
DisclosureSEC source: 0001712184-25-000017 · wk-form4_1738706760.xml · nonDerivative · entry 2 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,754 F2 · kind: Represents common shares that have been withheld by the Issuer to satisfy the tax liability in connection with the issuance of shares pursuant to the ESPP's "match benefit." Read SEC document |
| December 29, 2024 Filed Feb 4, 2025 22:06 UTC |
NOYES CHRISTOPHER JSVP, CHIEF FINANCIAL OFFICER
|
GrantClass C Common Shares | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000017 · wk-form4_1738706760.xml · nonDerivative · entry 1 NOYES CHRISTOPHER J · CIK 0001725072 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,824 F1 · kind: These shares were acquired pursuant to the "match benefit" of ESPP in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 29, 2024 Filed Feb 4, 2025 22:05 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
Tax withholdingClass C Common Shares | 212 | $6.38 | $1,352.56 |
DisclosureSEC source: 0001712184-25-000016 · wk-form4_1738706717.xml · nonDerivative · entry 2 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,485 F2 · kind: Represents common shares that have been withheld by the Issuer to satisfy the tax liability in connection with the issuance of shares pursuant to the ESPP's "match benefit." Read SEC document |
| December 29, 2024 Filed Feb 4, 2025 22:05 UTC |
WINTER JOHN MSVP, CLO AND SECRETARY
|
GrantClass C Common Shares | 368 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000016 · wk-form4_1738706717.xml · nonDerivative · entry 1 WINTER JOHN M · CIK 0001724412 · SVP, CLO AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,697 F1 · kind: These shares were acquired pursuant to the "match benefit" of ESPP in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 23, 2024 Filed Dec 23, 2024 21:50 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 18,011 | $6.12 | $110,207.51 |
DisclosureSEC source: 0001712184-24-000272 · wk-form4_1734990611.xml · nonDerivative · entry 2 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,518 F2 · price: The price reflects a weighted average of purchases made at prices ranging from $6.1150 to $6.1200. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:50 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 31,989 | $6.20 | $198,226.24 |
DisclosureSEC source: 0001712184-24-000272 · wk-form4_1734990611.xml · nonDerivative · entry 1 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,419,507 F1 · price: The price reflects a weighted average of purchases made at prices ranging from $6.1950 to $6.2000. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 04, 2024 Filed Dec 4, 2024 21:03 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass C Common Shares | 10,067 | $6.69 | $67,389.50 |
DisclosureSEC source: 0001712184-24-000270 · wk-form4_1733346210.xml · nonDerivative · entry 6 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,940,094 F6 · price: The price reflects a weighted average of purchases made at prices ranging from $6.6824 to $6.7085. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 04, 2024 Filed Dec 4, 2024 21:03 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 21,447 | $6.72 | $144,188.18 |
DisclosureSEC source: 0001712184-24-000270 · wk-form4_1733346210.xml · nonDerivative · entry 5 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,387,518 F5 · price: The price reflects a weighted average of purchases made at prices ranging from $6.7169 to $6.7264. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 21:03 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass C Common Shares | 14,259 | $6.89 | $98,233.10 |
DisclosureSEC source: 0001712184-24-000270 · wk-form4_1733346210.xml · nonDerivative · entry 4 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,930,027 F4 · price: The price reflects a weighted average of purchases made at prices ranging from $6.8500 to $6.9300. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 21:03 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 14,468 | $6.92 | $100,143.16 |
DisclosureSEC source: 0001712184-24-000270 · wk-form4_1733346210.xml · nonDerivative · entry 3 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,366,071 F3 · price: The price reflects a weighted average of purchases made at prices ranging from $6.9050 to $6.9500. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:03 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass C Common Shares | 25,674 | $6.98 | $179,320.05 |
DisclosureSEC source: 0001712184-24-000270 · wk-form4_1733346210.xml · nonDerivative · entry 2 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,915,768 F2 · price: The price reflects a weighted average of purchases made at prices ranging from $6.9475 to $6.9900. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:03 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 8,582 | $6.98 | $59,895.49 |
DisclosureSEC source: 0001712184-24-000270 · wk-form4_1733346210.xml · nonDerivative · entry 1 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,351,603 F1 · price: The price reflects a weighted average of purchases made at prices ranging from $6.9650 to $6.9900. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| November 29, 2024 Filed Nov 29, 2024 21:05 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 5,053 | $6.93 | $35,034.47 |
DisclosureSEC source: 0001712184-24-000262 · wk-form4_1732914323.xml · nonDerivative · entry 3 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,343,021 F3 · price: The price reflects a weighted average of purchases made at prices ranging from $6.9150 to $6.9500. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| November 27, 2024 Filed Nov 29, 2024 21:05 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 64,525 | $7.15 | $461,192.44 |
DisclosureSEC source: 0001712184-24-000262 · wk-form4_1732914323.xml · nonDerivative · entry 2 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,337,968 F2 · price: The price reflects a weighted average of purchases made at prices ranging from $7.1250 to $7.1500. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 21:05 UTC |
PADDICK BRENDAN JDirector
|
PurchaseClass A Common Shares | 35,475 | $7.04 | $249,903.64 |
DisclosureSEC source: 0001712184-24-000262 · wk-form4_1732914323.xml · nonDerivative · entry 1 PADDICK BRENDAN J · CIK 0001724506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,273,443 F1 · price: The price reflects a weighted average of purchases made at prices ranging from $7.0250 to $7.050. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:03 UTC |
Nair BalanDirector · President and CEO
|
PurchaseClass C Common Shares | 23,076 | $6.66 | $153,686.16 |
DisclosureSEC source: 0001712184-24-000257 · wk-form4_1731963796.xml · nonDerivative · entry 1 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,403,412 Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:05 UTC |
BRACKEN CHARLES H RDirector
|
GrantShare Appreciation Rights C · Derivative | 47,416 | Not disclosed Strike: $21.39 | Not disclosed |
DisclosureSEC source: 0001712184-24-000238 · wk-form4_1729800333.xml · derivative · entry 4 BRACKEN CHARLES H R · CIK 0001091974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,416 Underlying: Class C Common Shares · 47,416 shares Expires 2028-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:05 UTC |
BRACKEN CHARLES H RDirector
|
Disposition to issuerShare Appreciation Rights C · Derivative | 47,416 | Not disclosed Strike: $21.39 | Not disclosed |
DisclosureSEC source: 0001712184-24-000238 · wk-form4_1729800333.xml · derivative · entry 3 BRACKEN CHARLES H R · CIK 0001091974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 47,416 shares Expires 2025-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:05 UTC |
BRACKEN CHARLES H RDirector
|
GrantShare Appreciation Rights A · Derivative | 23,708 | Not disclosed Strike: $21.58 | Not disclosed |
DisclosureSEC source: 0001712184-24-000238 · wk-form4_1729800333.xml · derivative · entry 2 BRACKEN CHARLES H R · CIK 0001091974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,708 Underlying: Class A Common Shares · 23,708 shares Expires 2028-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:05 UTC |
BRACKEN CHARLES H RDirector
|
Disposition to issuerShare Appreciation Rights A · Derivative | 23,708 | Not disclosed Strike: $21.58 | Not disclosed |
DisclosureSEC source: 0001712184-24-000238 · wk-form4_1729800333.xml · derivative · entry 1 BRACKEN CHARLES H R · CIK 0001091974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 23,708 shares Expires 2025-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:04 UTC |
FRIES MICHAEL TDirector · Executive Chairman
|
GrantShare Appreciation Rights C · Derivative | 333,333 | Not disclosed Strike: $21.39 | Not disclosed |
DisclosureSEC source: 0001712184-24-000236 · wk-form4_1729800267.xml · derivative · entry 4 FRIES MICHAEL T · CIK 0001058725 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,333 Underlying: Class C Common Shares · 333,333 shares Expires 2028-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:04 UTC |
FRIES MICHAEL TDirector · Executive Chairman
|
Disposition to issuerShare Appreciation Rights C · Derivative | 333,333 | Not disclosed Strike: $21.39 | Not disclosed |
DisclosureSEC source: 0001712184-24-000236 · wk-form4_1729800267.xml · derivative · entry 3 FRIES MICHAEL T · CIK 0001058725 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 333,333 shares Expires 2025-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:04 UTC |
FRIES MICHAEL TDirector · Executive Chairman
|
GrantShare Appreciation Rights A · Derivative | 166,667 | Not disclosed Strike: $21.58 | Not disclosed |
DisclosureSEC source: 0001712184-24-000236 · wk-form4_1729800267.xml · derivative · entry 2 FRIES MICHAEL T · CIK 0001058725 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,667 Underlying: Class A Common Shares · 166,667 shares Expires 2028-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:04 UTC |
FRIES MICHAEL TDirector · Executive Chairman
|
Disposition to issuerShare Appreciation Rights A · Derivative | 166,667 | Not disclosed Strike: $21.58 | Not disclosed |
DisclosureSEC source: 0001712184-24-000236 · wk-form4_1729800267.xml · derivative · entry 1 FRIES MICHAEL T · CIK 0001058725 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 166,667 shares Expires 2025-01-02 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:06 UTC |
Nair BalanDirector · President and CEO
|
GrantShare Appreciation Rights C · Derivative | 441,468 | Not disclosed Strike: $10.48 | Not disclosed |
DisclosureSEC source: 0001712184-24-000239 · wk-form4_1729800377.xml · derivative · entry 16 Nair Balan · CIK 0001398905 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,468 Underlying: Class C Common Shares · 441,468 shares Expires 2030-03-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.